Introduction What Is This Book? Pediatric Psychopharmacology for Primary Care, 2nd Edition, provides primary care clinicians with a practical and coherent approach to initial prescribing and ongoing management of psychotropic medications for children and adolescents. The book has the following 5 parts: ■■ Conceptual Framework ■■ Practical Guidance ■■ Group 1 Medications for Specific Diagnoses: Attention Deficit/ Hyperactivity Disorder, Anxiety, and Depression ■■ Group 2 (FDA-approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications ■■ Advanced Topics The Table of Contents provides a detailed outline of each part. Each chapter is designed to “stand alone” so that, depending on the reader’s knowledge, skills, and experience, relevant chapters and sections may be specifically utilized. Additionally, numerous resources are included in the appendixes, with an emphasis on access to electronic content from the American Academy of Pediatrics (AAP). Selected Updates in Second Edition Newly approved medications, changes in regulations and guidelines, and updates in the professional literature are included in the second edition, including: ■■ Updated AAP guidelines for attention-deficit/hyperactivity disorder (ADHD) ■■ US Food and Drug Administration (FDA)–approved additional medica- tions for treating children and adolescents Methylphenidate extended release preparation for ADHD for ages 6 years and older. Amphetamine preparation for ADHD for ages 3 years and older.
Previous Page Next Page